A5010124235- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Vaccine Coverage and Hesitancy
- COVID-19 Clinical Research Studies
- COVID-19 epidemiological studies
- COVID-19 diagnosis using AI
Scientific Centre of Monaco
2021-2025
Several studies have shown that neutralising antibody level is a good biomarker for the correlate of protection against SARS-CoV-2 infection.1Bergwerk M Gonen T Lustig Y et al.COVID-19 breakthrough infections in vaccinated health care workers.N Engl J Med. 2021; 385: 1474-1484Crossref PubMed Scopus (836) Google Scholar, 2Khoury DS Cromer D Reynaldi A al.Neutralizing levels are highly predictive immune from symptomatic infection.Nat 27: 1205-1211Crossref (2073) 3Feng S Phillips DJ White...
<title>Abstract</title> <bold>Background</bold> Providing non-invasive, accurate and affordable SARS-CoV-2 tests represents a public health priority, to better control viral circulation while protecting healthcare workers. Saliva is robust alternative nasopharyngeal (NP) swab, but there heterogeneity in collection pre-analytical methods. <bold>Methods</bold> Relying on national COVID-19 Public Health Programme, we prospectively recruited 3,488 symptomatic asymptomatic adults attending the...
Providing non-invasive, accurate and affordable SARS-CoV-2 tests represents a public health priority, to better control the spread of virus while protecting healthcare workers. Saliva is robust alternative nasopharyngeal (NP) swabs, but there heterogeneity in collection pre-analytical methods. Relying on national COVID-19 Public Health Programme, we prospectively recruited 3,488 symptomatic asymptomatic adults attending Monaco community centre for NP RT-PCR testing from February 2021-2023....
Neutralising antibodies (nAbs) play a critical role in the protection against severe COVID-19. In era of vaccine boosters and repeated SARS-CoV-2 outbreaks, identifying individuals at risk represents public health priority.Relying on Monaco COVID Public Health Programme, we evaluated nAbs from July 2021-June 2022 8,080 vaccinated and/or infected children adults, their inclusion visit. We stratified by infection status investigated variables associated with using generalised additive...
Background Neutralising antibodies (nAbs) play a critical role in the protection against severe COVID-19. In era of vaccine boosters and repeated SARS-CoV-2 outbreaks, identifying individuals at risk represents public health priority. We aimed to evaluate nAb following vaccination and/or infection general population.Methods Relying on Monaco COVID Public Health Programme, we evaluated nAbs from July 2021-June 2022 8,080 vaccinated infected children adults, their inclusion visit. This...